Samsung Acquires French AI Firm Sonio to Enhance Medical Diagnostics

The $92 million deal aims to revolutionize prenatal ultrasound technology through advanced AI integration.

Samsung Medison, a subsidiary of Samsung Electronics, purchases Sonio for enhanced AI-driven ultrasound capabilities.
The acquisition, valued at approximately $92 million, underscores Samsung’s commitment to expanding its healthcare technology.
Sonio's AI technology, including the FDA-approved Sonio Detect, improves ultrasound image analysis and quality.
Post-acquisition, Sonio will operate as an independent entity but collaborate closely with Samsung Medison.
The deal is poised to improve medical diagnostics globally, especially in prenatal care and underserved healthcare areas.